Pathogenicity, transmissibility, and fitness of SARS-CoV-2 Omicron in Syrian hamsters.
Shuo-Feng YuanZi-Wei YeRonghui LiangKaiming TangAnna Jinxia ZhangGang LuChon Phin OngVincent Kwok-Man PoonChris Chung-Sing ChanBobo Wing-Yee MokZhenzhi QinYubin XieAllen Wing-Ho ChuWan-Mui ChanJonathan Daniel IpHaoran SunJessica Oi-Ling TsangTerrence Tsz-Tai YuenKenn Ka-Heng ChikChris Chun-Yiu ChanJian-Piao CaiCuiting LuoLu LuCyril Chik-Yan YipHin ChuKelvin Kai Wang ToHong-Lin ChenDong-Yan JinKwok-Yung YuenJasper Fuk-Woo ChanPublished in: Science (New York, N.Y.) (2022)
The in vivo pathogenicity, transmissibility, and fitness of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron (B.1.1.529) variant are not well understood. We compared these virological attributes of this new variant of concern (VOC) with those of the Delta (B.1.617.2) variant in a Syrian hamster model of COVID-19. Omicron-infected hamsters lost significantly less body weight and exhibited reduced clinical scores, respiratory tract viral burdens, cytokine and chemokine dysregulation, and lung damage than Delta-infected hamsters. Both variants were highly transmissible through contact transmission. In noncontact transmission studies Omicron demonstrated similar or higher transmissibility than Delta. Delta outcompeted Omicron without selection pressure, but this scenario changed once immune selection pressure with neutralizing antibodies-active against Delta but poorly active against Omicron-was introduced. Next-generation vaccines and antivirals effective against this new VOC are therefore urgently needed.